№ files_lp_4_process_1_36769
File format: docx
Character count: 64233
File size: 144 KB
This guideline offers evidence-based recommendations for the diagnosis and treatment of Chlamydia trachomatis infections, specifically addressing urogenital and extragenital testing, as well as treatment protocols.
Year:
2024
Region / city:
Europe
Theme:
Sexually transmitted infections, Chlamydia trachomatis
Document type:
Guideline
Organization:
European Health Institutions
Author:
John A White, Nicole HTM Dukers-Muijrers, Christian JPA Hoebe, Chris R Kenyon, Jonathan DC Ross, Magnus Unemo
Target audience:
Healthcare professionals, clinicians
Period of validity:
2024
Approval date:
N/A
Date of modifications:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2013
Region / City:
Ghana, West Africa
Topic:
Health / Infectious Diseases / Infertility
Document Type:
Research Study
Organization:
Not specified
Author:
Katie Busenbark
Target Audience:
Medical professionals, researchers
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Year
Year:
2022
Region:
Massachusetts
Jurisdiction:
United States
Topic:
Chlamydia infection; expedited partner therapy; sexually transmitted infections
Document type:
Clinical advisory
Issuing body:
Massachusetts Department of Public Health
Legal basis:
M.G.L. c. 111 § 121B; 105 CMR 700.003(J); 105 CMR 721.000
Target audience:
Healthcare providers and pharmacists
Standard treatment referenced:
Doxycycline; azithromycin
Population referenced:
Adolescents, young adults, men who have sex with men
Date of update:
January 28, 2022
Note:
Year
Region / city:
England
Topic:
Chlamydia testing and diagnoses
Document type:
Data request form
Organisation:
CTAD, UKHSA
Author:
Not specified
Target audience:
Organisations involved in sexual health care (NHS, service providers, Department of Health and Social Care, local government, partner organisations)
Validity period:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Year:
2022
Region / city:
Victoria, Australia
Topic:
Chlamydia treatment
Document type:
Official FAQ
Organization:
Victorian Government, Department of Health
Author:
Victorian Government
Target audience:
Patients diagnosed with chlamydia and their sexual partners
Period of validity:
N/A
Approval date:
June 2022
Date of last modification:
N/A
Note:
Year
Theme:
Microbiological diagnostics, Rickettsial infections, Chlamydia, Mycoplasma
Document type:
Educational material
Target audience:
Students, medical professionals
Contextual description:
A medical educational document focusing on the microbiological diagnostics of infections caused by rickettsia, chlamydia, and mycoplasma, detailing the properties, transmission, pathogenesis, clinical findings, and laboratory diagnosis of these infections.
Year:
2024
Institution:
Utrecht University; Wageningen University & Research
Type:
Master of Science research project
Supervisor:
Dr. Y.R.A. van Zeeland; Dr. R. Gehring; Dr. M. Heijne
Student:
T. Ploegers
Study period:
August 2019 – August 2020
Species studied:
Budgerigars and other avian species
Sample types:
Fecal and serum samples
Treatment methods:
Oral and intramuscular doxycycline
Objective:
Investigate residual excretion and pharmacokinetics of doxycycline
Ethical approval:
License AVD1080020184847 by CCD for university-collected samples
Source of field cases:
Dutch Food and Consumer Product Safety Authority (NVWA)
Version:
Final
Date:
August 4, 2024
Scope:
Zoonotic disease psittacosis, avian pharmacokinetics
Year:
2013
Region / City:
Ghana, West Africa
Topic:
Health / Infectious Diseases / Infertility
Document Type:
Research Study
Organization:
Not specified
Author:
Katie Busenbark
Target Audience:
Medical professionals, researchers
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / Country:
Global
Subject:
Veterinary virology, poultry diseases
Document type:
Scientific chapter
Institution / Organization:
Not specified
Target audience:
Veterinarians, poultry researchers, animal health specialists
Pathogen:
Avian metapneumovirus (aMPV)
Affected species:
Turkeys, chickens, ducks, pheasants, Muscovy ducks, Peking ducks, guinea fowl
Clinical signs:
Respiratory infection, reproductive disorders, swollen head syndrome, decreased egg production
Transmission:
Highly contagious, rapid spread through flocks
Diagnosis methods:
Virus isolation, RT-PCR, ELISA, immunofluorescence, virus neutralization
Serotypes / subgroups:
A, B, C, D
Public health relevance:
No human infections reported
Economic impact:
Losses in turkey and chicken flocks
Year:
2023
Region / City:
Australia
Theme:
Infectious Diseases Management, Healthcare
Document Type:
Guidelines
Organization:
Australian Government, Department of Health
Author:
Not specified
Target Audience:
Operators of residential care facilities
Action Period:
Ongoing
Approval Date:
16 May 2023
Amendment Date:
None
Context:
This document provides a comprehensive checklist for the management of acute respiratory infections, including COVID-19, influenza, and RSV, in residential care facilities.
Year:
1968
Region / City:
United Kingdom
Topic:
Vaccination, Measles, Immunology
Document Type:
Educational Text
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Students, Health professionals
Effective Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2021
Region / City:
United Kingdom
Subject:
Health economics, antimicrobial evaluation
Document type:
Final report
Organization / Institution:
Centre for Health Economics, University of York; Health Economics and Decision Science, University of Sheffield
Author:
Sue Harnan, Ben Kearns, Alison Scope, Laetitia Schmitt, Dina Jankovic, Jean Hamilton, Ruth Wong, Tushar Srivastava, Harry Hill, Chu Chang Ku, Kate Ren, Claire Rothery, Laura Bojke, Mark Sculpher, Beth Woods
Target audience:
Healthcare professionals, policymakers, researchers
Period of validity:
2016 - ongoing
Approval date:
October 2021
Date of last modification:
October 2021
Year:
2022
Region / city:
United Kingdom
Topic:
Healthcare, Infectious Diseases, Antimicrobial Resistance
Document Type:
Briefing Paper
Organization / Institution:
National Institute for Health and Care Excellence
Author:
NICE
Target Audience:
Healthcare professionals, Policy makers, Researchers
Period of validity:
Not specified
Approval Date:
12th July 2022
Date of Changes:
Not specified
Year:
2023
Region / City:
Atlanta, GA
Topic:
Public Health, Infectious Diseases
Document Type:
Non-Substantive Change Request
Organization / Institution:
U.S. Centers for Disease Control and Prevention (CDC)
Author:
Sonja Mali Nti-Berko, MPH
Target Audience:
Public Health Professionals, Epidemiologists, Researchers
Period of Action:
2023-2026
Approval Date:
12/21/2023
Date of Modifications:
N/A
Year:
2022
Region / city:
United Kingdom
Subject:
Health care, Medical guidelines
Document type:
Quality standard
Organization / institution:
National Institute for Health and Care Excellence (NICE)
Author:
National Institute for Health and Care Excellence (NICE)
Target audience:
Healthcare professionals, Service providers
Period of validity:
2022-2023
Approval date:
11 June 2015
Date of amendments:
6 September 2022
Note:
Contextual description
Year:
2021
Region/Country:
United Arab Emirates
Type of document:
Clinical guideline
Organization:
National Antimicrobial Stewardship Committee
Target population:
Adult outpatients, Adult inpatients, Pregnant women
Scope:
Empiric antibiotic management of urinary tract infections
Version:
1
Date of issue:
1 September 2021
Review period:
Every three years
Attachments:
Risk factors for complicated UTIs, Summary tables for empiric treatment, National cumulative antibiogram 2019
References:
CDC, IDSA, ESCMID, FDA standards
Year:
2021
Month:
August
Region:
England
Healthcare setting:
Primary care
Clinical area:
Paediatrics
Conditions covered:
Bronchiolitis; Viral induced wheeze; Viral lower respiratory tract infections
Document type:
Clinical guidance
Authors:
Clare Harris; Sanjay Patel; Zena Penny; David James; Sally Robins; Julia Shaw; Natalie Smith; Jo Borbone; Kathryn Bannell; Mark Alderton; Olie Morris; Sian Butterworth
Affiliated organisations:
Healthier Together; Hampshire CCGs; NHS England
Target audience:
Primary care clinicians
Patient population:
Infants and children
Referral pathways:
Primary to secondary care
Associated programmes:
Palivizumab programme
Guidance source:
Healthier Together clinical pathways
Year:
2018
Region / city:
Philadelphia, USA
Topic:
Biofilm-related musculoskeletal infections
Document type:
Summary report
Organization:
International Consensus Meeting on Musculoskeletal Infection
Author:
Kordo Saeed, Alex C. McLaren, Edward M. Schwarz, Valentin Antoci, William V. Arnold, Antonia F. Chen, Martin Clauss, Jaime Esteban, Vanya Gant, Edward Hendershot, Noreen Hickok, Carlos A. Higuera, Débora C. Coraça-Huber, Hyonmin Choe, Jessica Amber Jennings, Manjari Joshi, William T. Li, Philip C. Noble, K. Scott Phillips, Paul S. Pottinger, Camilo Restrepo, Holger Rohde, Thomas P. Schaer, Hao Shen, Mark Smeltzer, Paul Stoodley, Jason C. J. Webb, Eivind Witsø
Target audience:
Medical professionals, researchers, healthcare providers
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Context:
The document is a consensus report summarizing discussions and conclusions from the Biofilm Workgroup at the 2018 International Consensus Meeting on Musculoskeletal Infections, addressing clinical challenges related to biofilm-associated musculoskeletal infections.
Year:
2017
Region / City:
Not specified
Topic:
Healthcare, Urology, Infection Control
Document Type:
Guideline
Organization / Institution:
NHS Highland
Author:
Urology Nurse Specialist, Catherine Stokoe, Kathleen Mackenzie
Target Audience:
Healthcare professionals
Effective Period:
Not specified
Approval Date:
04.12.2017
Review Date:
Dec 2020
Year:
2012
Region / City:
UK
Topic:
Clinical microbiology, paediatric infections
Document Type:
Standard Operating Procedure (SOP)
Organization / Institution:
Health Protection Agency, UK
Author:
Not specified
Target Audience:
Medical professionals, laboratory staff
Period of validity:
Not specified
Approval Date:
December 2012
Date of Last Revision:
Not specified